D115 Unit 6 Cohort Notes: RAAS, Kidney Disorders, and GI Pathophysiology
Student Name
Western Governors University
D115 Advanced Pathophysiology for the Advanced Practice Nurse
Prof. Name
Date
Unit 6: Renin–Angiotensin–Aldosterone System (RAAS)
Purpose and Physiological Role of RAAS
The Renin–Angiotensin–Aldosterone System (RAAS) is an essential hormonal pathway that regulates systemic blood pressure, extracellular fluid volume, and electrolyte balance. This system serves as a compensatory mechanism activated in response to low blood pressure, reduced renal blood flow, or decreased sodium levels. Through RAAS activation, the body restores hemodynamic stability and maintains internal equilibrium.
What Triggers RAAS Activation?
RAAS is stimulated primarily when the kidneys detect:
A drop in arterial blood pressure
Reduced sodium concentration delivered to the distal renal tubules
Decreased circulating blood volume
These conditions signal the body to conserve sodium and water, thereby supporting the restoration of adequate blood pressure and ensuring proper tissue perfusion.
Step-by-Step Mechanism of RAAS Activation
| Step | Organ/Site | Action |
|---|---|---|
| 1 | Liver | Synthesizes and releases angiotensinogen into circulation |
| 2 | Kidney (juxtaglomerular cells) | Secretes renin in response to low renal perfusion |
| 3 | Blood | Renin enzymatically converts angiotensinogen into angiotensin I |
| 4 | Lungs (pulmonary endothelium) | Angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II |
| 5 | Adrenal cortex | Angiotensin II stimulates aldosterone secretion |
| 6 | Kidneys and blood vessels | Aldosterone promotes sodium retention; angiotensin II induces vasoconstriction |
What Are the Physiological Effects of Angiotensin II?
Angiotensin II acts as the primary effector hormone and exerts several effects:
Stimulates aldosterone release, enhancing sodium and water reabsorption in the kidneys
Facilitates potassium excretion to maintain electrolyte balance
Causes arteriolar vasoconstriction, which increases systemic vascular resistance and elevates blood pressure
Acute Pyelonephritis
What Is Acute Pyelonephritis?
Acute pyelonephritis is a bacterial infection involving one or both kidneys, targeting the renal pelvis, calyces, interstitial tissues, and renal tubules. It is a severe upper urinary tract infection that, if left untreated, can lead to irreversible kidney damage.
Who Is Most at Risk?
Factors increasing susceptibility include:
Urinary tract obstructions such as kidney stones or strictures
Vesicoureteral reflux, particularly in children
Female anatomical characteristics that facilitate ascending infections
Which Microbes Are Responsible?
The infection commonly arises from bacteria ascending from the lower urinary tract, primarily:
Escherichia coli (most common pathogen)
Proteus species
Pseudomonas aeruginosa
What Pathological Changes Occur?
The infection primarily damages renal tubules, resulting in:
Inflammatory fibrosis and scarring
Tubular atrophy due to repeated injury
Permanent loss of renal function after multiple infections
What Are the Symptoms?
Typical signs include:
High-grade fever and chills
Flank or groin pain
Dysuria (painful urination) and increased frequency
Tenderness over the costovertebral angle
Older adults may show atypical symptoms such as fatigue or mild fever instead of classic presentations.
How Is It Diagnosed and Treated?
Diagnosis depends on urinalysis showing white blood cell casts, urine culture, blood cultures, and imaging for complicated cases. Treatment includes a 2–3 week course of targeted antibiotics, with repeat cultures if symptoms persist.
Acute Glomerulonephritis
What Defines Acute Glomerulonephritis?
This condition involves inflammation and injury to the glomeruli, either as a primary renal disease or secondary to systemic disorders.
What Causes It?
Etiologies include:
Immune-mediated processes such as post-infectious glomerulonephritis
Infectious agents
Ischemia
Toxic exposures
Vascular diseases
How Does It Affect Kidney Function?
Inflammation damages the glomerular filtration barrier (endothelial cells, basement membrane, podocytes), reducing filtration efficiency and causing progressive nephron loss.
What Is the Clinical Course?
Symptoms may develop gradually, allowing significant renal damage before diagnosis. Severe cases can show oliguria (low urine output) and rapid renal function decline.
Diabetes Insipidus: Diagnosis and Management
How Is Diabetes Insipidus Diagnosed?
| Type of DI | Response to Desmopressin Test |
|---|---|
| Neurogenic (central) | Increase in urine osmolality |
| Nephrogenic | No significant change in urine osmolality |
What Are the Treatment Strategies?
Neurogenic DI:
Desmopressin replacement via oral, nasal, or intravenous routes
Treat underlying causes such as trauma or tumors
Nephrogenic DI:
Discontinue causative agents (e.g., lithium)
Ensure hydration and correct electrolyte imbalances
Use thiazide diuretics to reduce urine output
Modify diet by restricting sodium and protein intake
Gastroesophageal Reflux Disease (GERD)
What Is GERD?
GERD is a chronic condition characterized by the reflux of acidic stomach contents into the esophagus, leading to mucosal injury and inflammation.
How Does GERD Develop?
GERD results from failure of the lower esophageal sphincter (LES) to maintain adequate tone, allowing acid and pepsin to reflux. This may occur due to transient LES relaxations or anatomical weaknesses.
What Factors Exacerbate GERD?
Factors increasing intra-abdominal pressure, such as obesity, pregnancy, coughing, vomiting, or heavy lifting, worsen reflux symptoms.
What Are the Common Symptoms?
Heartburn and epigastric discomfort post-meals
Chronic cough and hoarseness
Asthma exacerbations and sinus infections
How Is GERD Diagnosed?
Upper endoscopy with biopsy is utilized to assess esophageal mucosal damage and rule out premalignant lesions like Barrett’s esophagus.
What Treatments Are Available?
| Treatment Category | Description |
|---|---|
| First-line | Proton pump inhibitors (PPIs), e.g., omeprazole |
| Second-line | H2 receptor antagonists, e.g., famotidine |
| Adjunctive | Antacids, prokinetic agents |
| Lifestyle | Weight loss, dietary modifications, bed elevation |
| Surgical | Laparoscopic fundoplication for refractory cases |
Glomerulonephritis Overview
What Is Glomerulonephritis?
A group of inflammatory disorders affecting the glomeruli, leading to impaired filtration and fluid regulation.
Types and Causes
| Type | Features |
|---|---|
| Acute | Sudden onset, often post-infectious |
| Chronic | Gradual progression, leading to CKD |
Common causes encompass infections, autoimmune disorders, drug toxicity, hypertension, diabetes, genetics, and malignancies.
Clinical Features
Acute: hematuria, edema, hypertension
Chronic: proteinuria, nocturia, fatigue, generalized edema
Diagnosis and Management
Diagnosis includes laboratory tests, imaging, and renal biopsy. Treatment ranges from antibiotics to immunosuppressants, combined with blood pressure control and dietary adjustments. Advanced cases may need dialysis or transplantation.
Nephrotic Syndrome
Definition and Features
Characterized by heavy proteinuria (>3.5 g/day), low plasma albumin, widespread edema, and elevated lipid levels.
Pathophysiology
Damage to the glomerular filtration barrier increases permeability, causing protein loss and lowered oncotic pressure. This promotes fluid movement into tissues and activates RAAS, aggravating edema.
Causes
Primary: minimal change disease, focal segmental glomerulosclerosis
Secondary: diabetes, amyloidosis, infections, systemic diseases
Complications
Increased risk of infections, blood clots, malnutrition, and cardiovascular disease.
Management
| Aspect | Recommendations |
|---|---|
| Dietary | Balanced protein intake; sodium restriction; caloric control |
| Pharmacologic | Corticosteroids, immunosuppressants, diuretics, ACE inhibitors/ARBs |
| Complication Control | Blood pressure management, thromboembolism prevention, infection prophylaxis, volume support |
Peptic Ulcer Disease (PUD) Overview
What Is PUD?
PUD involves erosions or ulcers in the mucosa of the lower esophagus, stomach, or duodenum caused by acid and pepsin injury.
Risk Factors
Helicobacter pylori infection
Chronic NSAID or aspirin use
Smoking and alcohol use
Other factors: chronic illness, obesity, older age, socioeconomic status, genetics
Types and Symptoms
| Ulcer Type | Location | Clinical Features |
|---|---|---|
| Gastric | Stomach | Pain worsens after eating, weight loss, early satiety |
| Duodenal | Duodenum | Pain relieved by food, often nocturnal |
| Esophageal | Esophagus | GERD symptoms, dysphagia |
Diagnosis
Upper GI endoscopy with biopsy, H. pylori testing (biopsy or stool antigen), and blood tests for anemia.
Treatment
| Condition | Approach |
|---|---|
| H. pylori-positive | Triple therapy (clarithromycin-based) or quadruple therapy with PPIs |
| H. pylori-negative | Proton pump inhibitors, avoid ulcerogenic drugs |
| Lifestyle | Avoid NSAIDs, alcohol, smoking; surgery for refractory cases |
Pyelonephritis Overview
What Is Pyelonephritis?
An infection affecting the kidney pelvis, calyces, and interstitial tissue, presenting either acutely or chronically due to recurrent infections.
Etiology and Progression
Most often caused by E. coli, with Proteus and Pseudomonas as other pathogens. Acute infections cause inflammation and purulent urine; chronic cases lead to fibrosis and impaired concentrating ability.
Clinical Features
Acute: fever, chills, flank pain, urinary symptoms
Chronic: hypertension, renal failure, metabolic disturbances
Diagnosis and Treatment
Confirmed by urinalysis and culture; imaging for chronic cases. Treatment includes prolonged antibiotics and correction of anatomical abnormalities.
Renal Calculi (Kidney Stones)
Overview and Formation
Kidney stones are crystalline aggregates formed in supersaturated urine. Their formation depends on factors like supersaturation, crystal nucleation and growth, and reduced inhibition by substances such as citrate.
Urine pH and Stone Type
| Urine pH | Stone Type |
|---|---|
| >7.0 | Calcium phosphate |
| <5.0 | Uric acid |
Management and Prevention
Treatment includes pain control, hydration, facilitating stone passage, lithotripsy, or surgery for large stones. Prevention involves increased fluid intake, sodium restriction, moderated animal protein consumption, and balanced calcium intake.
Renal Failure Overview
Acute vs. Chronic Renal Failure
Renal failure impairs filtration and fluid/electrolyte balance. Acute renal failure may be prerenal, intrarenal, or postrenal, while chronic kidney disease (CKD) progresses irreversibly over time.
Dialysis Modalities
Hemodialysis and continuous renal replacement therapies assist in waste and fluid removal but do not restore kidney function.
Urinary Tract Infections (UTIs)
What Are UTIs?
UTIs are bacterial infections of the urinary tract, predominantly caused by Escherichia coli.
Risk Factors
Include sexual activity, pregnancy, menopause, urinary obstruction, and poor hygiene.
Clinical Presentation and Management
| UTI Type | Symptoms | Treatment |
|---|---|---|
| Cystitis | Dysuria, urgency, suprapubic pain | Antibiotics, hydration |
| Pyelonephritis | Fever, chills, flank pain, systemic signs | Prolonged antibiotics, imaging |
Diagnosis relies on urinalysis and culture, with treatment tailored to the causative pathogen and patient status.
Summary of RAAS
| Step | Organ/Site | Action |
|---|---|---|
| 1 | Liver | Releases angiotensinogen |
| 2 | Kidney | Renin converts angiotensinogen to angiotensin I |
| 3 | Lungs | ACE converts angiotensin I to angiotensin II |
| 4 | Adrenal cortex | Secretes aldosterone |
| 5 | Kidneys and vessels | Sodium retention and vasoconstriction |
Pharmacological inhibitors such as ACE inhibitors and angiotensin receptor blockers (ARBs) are pivotal in treating hypertension and renal diseases by interrupting this cascade.
References
Centers for Disease Control and Prevention. (2023). Urinary tract infection (UTI). https://www.cdc.gov
Feldman, M., Friedman, L. S., & Brandt, L. J. (2021). Sleisenger and Fordtran’s gastrointestinal and liver disease (11th ed.). Elsevier.
Guyton, A. C., & Hall, J. E. (2021). Textbook of medical physiology (14th ed.). Elsevier.
Kasper, D. L., Fauci, A. S., Hauser, S. L., Longo, D. L., Jameson, J. L., & Loscalzo, J. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill.
Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins and Cotran pathologic basis of disease (10th ed.). Elsevier.
D115 Unit 6 Cohort Notes: RAAS, Kidney Disorders, and GI Pathophysiology
McCance, K. L., & Huether, S. E. (2019). Pathophysiology: The biologic basis for disease in adults and children (8th ed.). Elsevier.
National Institute of Diabetes and Digestive and Kidney Diseases. (2023). Kidney disease and renal failure. https://www.niddk.nih.gov
Sung, J. J. Y., Kuipers, E. J., & El-Serag, H. B. (2020). Systematic review: The global incidence and prevalence of peptic ulcer disease. Alimentary Pharmacology & Therapeutics, 29(9), 938–946.
UpToDate. (2024). Management of nephrotic syndrome, pyelonephritis, and renal calculi. Wolters Kluwer.
Get WGU Free MSN Samples
D024
- D024 SEI Skill Sets Discussion – Self-Awareness & Management Insights
- D024 Phase 1 Video Reflection
- D024 CPE Schedule and SEI Reflection Report
- D024 FAQ: Submission and CPE Record Guidance
- D024 Phase 1 Reflection on Leadership and Growth Strategies
- D024 Joy in the Workplace: Force Field Analysis Summary
- D024 Professional Presence & Influence: CPE Record Template Task 1
D025
- D025 Phase 2 Reflection: Insights on Team Leadership and Advocacy
- D025: Phase 1 Reflection on Health Policy Advocacy Insights
- D025 Task 1: Clinical Practice Experience
- D025 Task 1 ISBAR Summary
- D025 Final Exam: Advocacy for Policy Change in Community Health
- D025 Task 2 Advocating for Policy Change to Improve Health Outcomes in the Community
D026
D027
- D027 Alzheimer’s Disease (AD) Final Synthesis: Understanding Key Aspects
- D027 OA Final Exam Study Guide: Key Concepts and Conditions
- D027 Shadow Health Treatment Plan for Dr. Douglas: Phase 3 Guide
- D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries
- D027 – Comprehensive Study Guide for Health Disorders and Treatments
- D027 E-Portfolio: Advanced Pathopharmacological Foundations
- D027 Study Guide – Advanced Pathopharmacology Notes
D028
D029
- D029 Narrative Essay: Innovations in Nursing Informatics
- D029 CPE Phase 2
- D029 Emerging Tech Annotated Bibliography for Nursing Care
- D029 Annotated Bibliography
- D029 Population Health Data Paper
- D029 Task 1 E-Portfolio: Clinical Practice Experience Analysis
- D029 Task 1: Analyzing Population Health Data in Strafford Country
D030
D031